To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
TMRW Life Sciences nets $25 mln Series B
New York City-based TMRW Life Sciences, a provider of an integrated platform for automated, software-guided embryology and cryo-management, has secured $25 million in Series B funding.
